Hostname: page-component-745bb68f8f-b95js Total loading time: 0 Render date: 2025-02-11T09:17:45.616Z Has data issue: false hasContentIssue false

An unusual case of paediatric Behçet’s disease with severe stenosis of the abdominal aorta and recurrent venous thrombi

Published online by Cambridge University Press:  24 February 2022

Şenay Akbay
Affiliation:
Department of Pediatric Cardiology Akdeniz University Faculty of Medicine, Antalya, Turkey
Filiz Ekici*
Affiliation:
Department of Pediatric Cardiology Akdeniz University Faculty of Medicine, Antalya, Turkey
Elif Çomak
Affiliation:
Department of Pediatric Rheumatology Akdeniz University Faculty of Medicine, Antalya, Turkey
*
Author for correspondence: Filiz Ekici, MD, Department of Pediatric Cardiology, Akdeniz University Faculty of Medicine, Antalya, Turkey. Tel: +90 242 2496543; Fax: +90 242 347 23 30; GSM: +90 (505) 466 36 20. E-mail: ekicifiliz@gmail.com
Rights & Permissions [Opens in a new window]

Abstract

Type
Brief Report
Copyright
© The Author(s), 2022. Published by Cambridge University Press

Behçet’s disease is a multisystemic inflammatory disease. Behçet’s disease is usually observed in young adults; however, up to 26 % of cases are in childhood.Reference Yıldız, Köker and Adrovic1 The vascular involvement is the initial sign of Behçet’s disease in 27.5 % of adult patients and usually presented with recurrent superficial or deep vein thrombosis in the lower extremities.Reference Demirelli, Degirmenci and Inci2,Reference Seyahi3 Arterial lesions are the least frequent and develop between 5 and 18 % of adult cases.Reference Demirelli, Degirmenci and Inci2 Arterial stenosis is also uncommon complications with a prevalence rate of less than 5%.Reference Seyahi3 Stenosis of the abdominal aorta due to Behçet’s disease has not been reported in childhood before. Here, we reported a child presenting with unusual cardiovascular findings and discussed the challenge in diagnosis of vascular Behçet’s disease in paediatric cases.

Case

A 15-year-old girl admitted with complaints of shortness of breath, palpitation, and headache. She had a history of intermittent arthralgia for 2 years. On admission, patient blood pressure of right arm and left leg was 219/126 and 110/80 mmHg, respectively. Renal Doppler ultrasonography showed severe stenosis in the abdominal aorta before giving truncus coeliacus and mesenteric artery branches. Aortic lumen showed 90% narrowing. Long segment (27 mm) stenosis in abdominal aorta with gradient of 70 mmHg was detected in subcostal examination at echocardiography. Aortic CT angiography showed diffuse increase in the wall thickness in the whole descending aorta. The lumen diameter of aorta abruptly decreased to 3 mm, especially at the level of the diaphragmatic hiatus (Fig 1). All these radiological findings were consistent with large vessel vasculitis. Ocular examination was normal; arterial and venous angiographic examinations of cranium and all extremities were normal. The pathergy test was negative. In laboratory tests; haemoglobin level was 11.7 g/dl, white blood cell count was 8.330 per mm3, and platelet count was 306.000 per mm3. C-reactive protein level (18.5 mg/L, upper limit: 5 mg/L) and erythrocyte sedimentation rate (24 mm per hour) were also high. Thrombose panel was normal, except mild decrease in Protein C, and high D-dimer (1.6 mg/L, upper limit 0.55 mg/L) and ferritin level (212 mg/L upper limit: 150 mg/L). Autoantibodies for collagen tissue disease and HLA B51 were negative. There was no laboratory evidence for bacterial, viral agents, and mycobacterium tuberculosis. Whole body PET scintigraphy showed an increased activity in abdominal aortic wall and bilateral femoral arteries. Then, intravenous immunosuppressive (cyclophosphamide and corticosteroid) treatment was started with the diagnosis of Behçet’s disease or Takayasu arteritis type 4. On the third day of treatment, a swelling in antecubital region of the right arm of the patient developed. Superficial Doppler USG was displayed on a thrombus in the lumen of vena basilica. Then, anticoagulant therapy with enoxaparin was started. Although immunosuppressive treatment and anticoagulant therapy at prophylaxis dose, a thrombus was detected in abdominal aorta just above the stenotic segment by transthoracic echocardiographic examination at the second month of treatment. Thrombus disappeared with enoxaparin treatment. Heterozygous p. Thr68Met (c.203C>T) alteration detected in the PSTPIP1 gene known as one of the rare genes associated with Behçet’s disease and colchicine therapy was initiated with the diagnosis of Behçet’s disease. Despite 1-year immunosuppressive therapy, no regression was detected in the diameter of the stenotic area of abdominal aorta and stent implantation was successfully performed in other cardiac centre. After stent implantation, it was observed that the patient’s arterial blood pressure was normalised.

Figure 1. CT angiography shows a) that there was diffuse increase in the wall thickness (red arrow) in the descending aorta, the aortic wall was concentrically thickened. b) Aortic wall thickening progressively increased and the diameter of the thoracic aorta decreased abruptly (red arrow) at the level of the diaphragmatic hiatus up to coeliac trunk in axial slices. c) There is abrupt decrease (yellow arrow) in aorta up to coeliac trunk in 3D surface shaded image and MIP image.

Discussion

Up to 80% of paediatric cases do not fulfil the international criteria of Behçet’s disease.Reference Guzelkucuk, Gokcebay and Bilir4 Also, our case did not meet the criteria of the “Full International Study Group Criteria” as in many children. Similarly, it was found that she did not meet the “International Criteria for Behçet’s Disease” and “New Pediatric Behçet’s Disease Criteria”. Acute phase reactants did not guide to show activation of the vasculitis. However, PET scintigraphy was suggestive for active vasculitis. CT angiography showed the inflammation of the whole abdominal aortic wall and these findings indicated large vessel vasculitis. In genetic evaluation, heterozygous p. Thr68Met (c.203C>T) change was detected in the PSTPIP1 gene, which was previously shown in paediatric-onset Behçet’s disease.Reference Burillo-Sanz, Montes-Cano and García-Lozano5 We experienced a diagnostic dilemma; was it large vessel vasculitis? or Behçet’s disease? Because of extensive vascular involvement, coexistence of stenosis and thrombosis, and genetic features, it was accepted as Behçet’s disease. Although “pathergy test, HLA B5 and HLA B51” are negative, there are children diagnosed with Behçet’s disease with vascular findings in the literature.Reference Demir, Sag and Kaya Akca6

Arterial lesions in Behçet’s disease are seen in the form of stenosis, occlusions, aneurysms, or aortitis.Reference Ben-David, Gur and Ilivitzki7 Kuzu et alReference Kuzu, Özaslan and Köksoy8 reported arterial aneurysm in 1.6% of 1200 patients. They found arterial stenosis in only three patients. Abdominal aortic stenosis has not been described previously in paediatric-onset Behçet’s disease. In 2018, a 20-year-old female with paediatric-onset Behçet’s disease was reported with bilateral subclavian arterial stenosis.Reference Pandiarajan, Manphool and Deepti9 Nakamura et alReference Nakamura, Ueki and Horikami10 reported a 18-year-old girl paediatric-onset Behçet’s disease case with a widespread narrowing of the carotid, vertebral, renal, subclavian arteries, and the abdominal aorta. Arterial stenotic lesions mimicking Takayasu arteritis, though fairly reported in adults, are previously not described in paediatric-onset Behçet’s disease.

Treatment of vascular Behçet’s disease includes combination therapy of systemic corticosteroid and immunosuppressants. Recently, recombinant interferon-alpha 2a and anti-TNF-α antiagents have been reported as an alternative treatment for management of vascular Behçet’s disease.Reference Yıldız, Köker and Adrovic1 There is no agreement for anticoagulation in case of thrombosis related to Behçet’s disease. Due to risk of recurrences, immunosuppressants should be the first choice of drug before surgical excision of thrombosis. Presence of arterial stenotic lesions indicates a worse prognosis and requires long-term immunosuppressive therapy. The treatment choices of abdominal aortic stenosis include surgical patch aortoplasty, thoracoabdominal bypass, and endovascular angioplasty with stenting; however, there are risks for thrombosis of the graft and relapses of aneurysms at the site of bypass.

Conclusion

Behçet’s disease should be kept in mind in vascular findings in childhood, even if there is no classical clinical triad of Behçet’s disease. The stenosis of the abdominal aorta was described in our paediatric-onset Behçet case for the first time.

Acknoledgements

For the CT images, We would like to thank Prof. Dr. Gökhan Arslan.

Financial support

This research received no specific grant from any funding agency, commercial, or not-for-profit sectors.

Conflict of interest

None.

Ethical standards

A written informed consent was obtained from the patient.

Author contributions

Dr Şenay Akbay: Concept/design, data analysis/interpretation, drafting article.

Prof. Dr Filiz Ekici: Concept/design, data analysis/interpretation, drafting article, critical revision of article.

Assoc. Prof. Dr Elif Çomak: Data analysis/interpretation.

References

Yıldız, M, Köker, O, Adrovic, A, et al. Pediatric behçet’s disease-clinical aspects and current concepts. Eur J Rheumatol 2020; 7: 38.CrossRefGoogle Scholar
Demirelli, S, Degirmenci, H, Inci, S, et al. Cardiac manifestations in behçet’s disease. Intractable Rare Dis Res 2015; 4: 7077.CrossRefGoogle ScholarPubMed
Seyahi, E. Behçet’s disease: how to diagnose and treat vascular involvement. Best Pract Res Clin Rheumatol 2016; 30: 279295.CrossRefGoogle ScholarPubMed
Guzelkucuk, Z, Gokcebay, DG, Bilir, OA, et al. Children with behçet disease-associated thrombosis: a single-center experience. J Pediatr Hematol Oncol 2020; 43: 1518.CrossRefGoogle Scholar
Burillo-Sanz, S, Montes-Cano, MA, García-Lozano, JR, et al. Mutational profile of rare variants in inflammasome-related genes in behçet disease: a next generation sequencing approach. Sci Rep 2017; 16: 8453.CrossRefGoogle Scholar
Demir, S, Sag, E, Kaya Akca, U, et al. The challenge of treating pulmonary vasculitis in behçet disease: two pediatric cases. Pediatrics 2019; 144: e20190162.CrossRefGoogle ScholarPubMed
Ben-David, Y, Gur, M, Ilivitzki, A, et al. Atypical cardiopulmonary manifestations in pediatric behçet’s disease. Pediatr Pulmonol 2020; 55: 34073413.CrossRefGoogle ScholarPubMed
Kuzu, MA, Özaslan, C, Köksoy, C, et al. Vascular involvement in behçet’s disease: 8-Year audit. World J Surg 1994; 18: 948953.CrossRefGoogle ScholarPubMed
Pandiarajan, V, Manphool, S, Deepti, S, et al. Extensive oral scarring and bilateral subclavian artery stenosis in pediatric-onset behçet’s disease. J Clin Rheumatol 2020; 26: 9192.Google Scholar
Nakamura, H, Ueki, Y, Horikami, K, et al. Vasculo-Behçet’s syndrome with widespread arterial involvement. Mod Rheumatol 2001; 11: 332335.CrossRefGoogle ScholarPubMed
Figure 0

Figure 1. CT angiography shows a) that there was diffuse increase in the wall thickness (red arrow) in the descending aorta, the aortic wall was concentrically thickened. b) Aortic wall thickening progressively increased and the diameter of the thoracic aorta decreased abruptly (red arrow) at the level of the diaphragmatic hiatus up to coeliac trunk in axial slices. c) There is abrupt decrease (yellow arrow) in aorta up to coeliac trunk in 3D surface shaded image and MIP image.